|
Evaluation of Patients with Known or Suspected Heart Disease Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Evaluation of Patients with Known or Suspected Heart Disease conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Evaluation of Patients with Known or Suspected Heart Disease Clinical research trials and Evaluation of Patients with Known or Suspected Heart Disease healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Evaluation of Patients with Known or Suspected Heart Disease. Evaluation of Patients with Known or Suspected Heart Disease Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Evaluation of Patients with Known or Suspected Heart Disease clinical trial. Human subjects often receive the most effective healthcare possible for their Evaluation of Patients with Known or Suspected Heart Disease condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation of Patients with Known or Suspected Heart Disease  Evaluation of Patients with Known or Suspected Heart Disease
Evaluation of Patients with Known or Suspected Heart Disease
For Condition: Chest Pain,Coronary Disease,Heart Disease,Hypertrophic Cardiomyopathy,Syndrome X
Status: Recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). Patients participating in this study will undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test. These tests are designed to assess the types and causes of patient's heart diseases and to determine if they can participate in other, specific research studies.
Details: The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols. However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine protocol eligibility by means of conventional laboratory and cardiovascular testing.
Eligibility:
Study Type: Observational, Screening
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol: 1. Coronary artery disease with effort or rest angina or inducible myocardial ischemia as determined by noninvasive testing. 2. Cardiomyopathies, including restrictive, congestive, and hypertrophic phenotypes. 3. Peripheral artery disease with intermittent claudication or limb-threatening ischemia. 4. Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy. 5. Upper extremity peripheral artery disease. 6. Symptomatic supraventricular and ventricular arrhythmias. EXCLUSION CRITERIA: Pregnancy, for those patients who require catheterization-based diagnostics. Inability to provide informed consent.
Total Enrollment: 9999
Location and Contact Information:
National Heart, Lung and Blood Institute (NHLBI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 920189; 92-H-0189
Study Start Date: May 10, 1992
Record last reviewed: March 19, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001313
Other Hypertrophic Cardiomyopathy Studies:
1. Evaluation of Patients with Known or Suspected Heart Disease
2. Analysis of Heart Muscle Function in Patients with Heart Disease and Normal Volunteers
Related Studies:
Other Hypertrophic Cardiomyopathy Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Evaluation of Patients with Known or Suspected Heart Disease
|
|
|
|
|
|
|
|
